06-10-2021, 10:27 PM
Pfizer and Swiss drugmaker Roche Holding AG (ROG.S) are also racing to develop an easy-to-administer antiviral pill for COVID-19. For now, only antibody cocktails that have to be given intravenously are approved for non-hospitalized patients.
https://www.reuters.com/business/healthc...021-10-01/
https://www.reuters.com/business/healthc...021-10-01/